Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration...
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster.
Precision for Medicine, a...
Xaira is an integrated biotechnology company built to deliver on the promise of artificial intelligence to help transform drug discovery and development
Xaira Therapeutics announced...
The Next platform will analyze clinical data from mBC patients treated in certain centers and notify clinicians when ESR1 testing is missing at disease progression.
Tempus AI,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new collaboration with the...
The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to drive next-gen therapeutic development...